Two Way Crossover Oral Drug-drug Interaction Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug) in Healthy Adult Human Subjects Under Fasting Condition
An open label, balanced, randomized, single-dose, two-treatment, two-sequence, two-period, crossover oral drug-drug interaction study of spironolactone (perpetrator) and Digoxin (substrate drug) in healthy adult human subjects under fasting condition.
100 项与 Cmp Development Sdn. Bhd. 相关的临床结果
0 项与 Cmp Development Sdn. Bhd. 相关的专利（医药）
100 项与 Cmp Development Sdn. Bhd. 相关的药物交易
100 项与 Cmp Development Sdn. Bhd. 相关的转化医学
